Head and Neck Diseases by Alexandros G.Sfakianakis: Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization associated with a dome-shaped macula in pathologic myopia.

Σάββατο 12 Μαΐου 2018

Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization associated with a dome-shaped macula in pathologic myopia.

http:--www.nature.com-images-lo_npg.gif

https:--www.ncbi.nlm.nih.gov-corehtml-pm

Related Articles

Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization associated with a dome-shaped macula in pathologic myopia.

Eye (Lond). 2017 03;31(3):507-508

Authors: Lee JH, Lee SC, Choi S, Koh HJ, Kim SS, Lee CS

PMID: 27813523 [PubMed - indexed for MEDLINE]

https://ift.tt/2wByDpH

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Εγγραφή σε: Σχόλια ανάρτησης (Atom)